EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell

Jillian Collins, Jessie M Barra, Keifer Holcomb, Andres Ocampo, Ashton Fremin, Austin Kratz, Jubril Akolade, Julianna K Hays, Ali Shilleh, Amit Sela, David J Hodson, Johannes Broichhagen iD und 2 weitere

ACS Applied Bio Materials · 2024

DOI: 10.1021/acsabm.4c00621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Jillian Collins und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado 80401, United States. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Polyesters, Nanocapsules, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Medical Research Council, American Diabetes Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsPolyestersNanocapsulesPeptidesHumansAnimalsMiceDrug Delivery SystemsParticle SizeMaterials TestingBiocompatible MaterialsExenatide

Stichwörter der Autor:innen

diabetesnanocapsulesnanomedicinepancreatic isletspolycaprolactonetargeted drug deliveryβ-cell

Substanzen

polycaprolactonePolyestersNanocapsulesPeptidesBiocompatible MaterialsExenatide

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado 80401, United States.
  • Depart of Pharmacology and Therapeutics, Diabetes Institute, University of Florida, Gainesville, Florida 32610, United States.
  • Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom.
  • Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Roessle-Str. 10, Berlin 13125, Germany.

ORCID-Profile: Johannes Broichhagen, Holger A Russ, Nikki L Farnsworth

Förderung

  • NIDDK NIH HHS
  • Medical Research Council
  • American Diabetes Association
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Diabetes UK
  • Juvenile Diabetes Research Foundation International
  • H2020 European Research Council

Zitieren

APA

Collins, J., Barra, J. M., Holcomb, K., Ocampo, A., Fremin, A., Kratz, A., Akolade, J., Hays, J. K., Shilleh, A., Sela, A., Hodson, D. J., Broichhagen, J., Russ, H. A., & Farnsworth, N. L. (2024). Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00621

Vancouver

Collins J, Barra JM, Holcomb K, Ocampo A, Fremin A, Kratz A, et al. Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00621

BibTeX
@article{Collins2024,
  author = {Collins, Jillian and Barra, Jessie M and Holcomb, Keifer and Ocampo, Andres and Fremin, Ashton and Kratz, Austin and Akolade, Jubril and Hays, Julianna K and Shilleh, Ali and Sela, Amit and Hodson, David J and Broichhagen, Johannes and Russ, Holger A and Farnsworth, Nikki L},
  title = {Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  doi = {10.1021/acsabm.4c00621}
}
Kostenlos starten →